HALOZYME THERAPEUTICS INC (HALO) Stock Analyst Earnings Estimates
NASDAQ:HALO - Nasdaq - US40637H1095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 443.3M 65.66% | 660.1M 48.91% | 829.253M 25.63% | 1.024B 23.48% | 1.21B 18.16% | 1.495B 23.55% | 1.686B 12.78% | 1.862B 10.44% | 1.723B -7.47% | 1.603B -6.96% | 1.485B -7.36% | 1.268B -14.61% | |
| EBITDA YoY % growth | 278.9M 88.96% | 339M 21.55% | 424.93M 25.35% | 629.08M 48.04% | 789.58M 25.51% | 1.06B 34.25% | 1.106B 4.34% | 1.218B 10.13% | 1.14B -6.40% | 1.046B -8.25% | N/A | N/A | |
| EBIT YoY % growth | 275.9M 91.20% | 289.4M 4.89% | 340.074M 17.51% | 555.31M 63.29% | 693.47M 24.88% | 938.26M 35.30% | 1.072B 14.25% | 1.315B 22.67% | 1.075B -18.25% | 1.001B -6.88% | 846.6M -15.42% | 603.84M -28.67% | |
| Operating Margin | 62.24% | 43.84% | 41.01% | 54.23% | 57.31% | 62.76% | 63.58% | 70.62% | 62.39% | 62.45% | 57.01% | 47.62% | |
| EPS YoY % growth | 1.92 113.33% | 2.22 15.62% | 2.78 25.23% | 4.21 51.47% | 5.15 22.35% | 6.67 29.38% | 8.01 20.12% | 9.21 15.00% | 8.72 -5.25% | 8.30 -4.91% | 7.00 -15.59% | 5.75 -17.84% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.18 44.08% | 0.99 25.52% | 1.21 32.94% | 1.41 11.03% | 1.54 30.48% | 1.56 57.38% | 1.68 39.12% | 1.81 28.04% | 1.80 16.45% |
| Revenue Q2Q % growth | 294.01M 27.81% | 237.12M 21.05% | 285.1M 23.23% | 339.62M 17.08% | 355.73M 20.99% | 333.54M 40.66% | 369.24M 29.51% | 396.78M 16.83% | 391.68M 10.11% |
| EBITDA Q2Q % growth | 189.27M 1.82% | 151.48M 30.87% | 173.97M 10.27% | 218.67M -2.42% | 235.84M 24.61% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 162.11M 60.45% | 127.83M 33.79% | 168.78M 43.97% | 210.16M 28.78% | 219.17M 35.20% | 215.22M 68.36% | 232.56M 37.79% | 250.92M 19.39% | 246.84M 12.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.27 69.33% | 1.00 | 0.27 | 26.79% |
| Q2 2024 Q2Q % growth | 0.91 22.97% | 0.77 | 0.14 | 17.68% |
| Q1 2024 Q2Q % growth | 0.79 68.09% | 0.71 | 0.08 | 11.44% |
| Q4 2023 Q2Q % growth | 0.82 70.83% | 0.84 | -0.02 | -2.55% |
| Q3 2023 Q2Q % growth | 0.75 1.35% | 0.72 | 0.03 | 3.96% |
| Q2 2023 Q2Q % growth | 0.74 39.62% | 0.64 | 0.10 | 15.31% |
| Q1 2023 Q2Q % growth | 0.47 | 0.49 | -0.02 | -3.40% |
| Q4 2022 Q2Q % growth | 0.48 14.29% | 0.48 | 0.00 | 1.02% |
| Q3 2022 Q2Q % growth | 0.74 45.10% | 0.52 | 0.22 | 41.37% |
| Q2 2022 Q2Q % growth | 0.53 -14.52% | 0.51 | 0.02 | 3.58% |
| Q1 2022 Q2Q % growth | 0.47 27.03% | 0.50 | -0.03 | -5.96% |
| Q4 2021 Q2Q % growth | 0.42 -16.00% | 0.41 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.51 104.00% | 0.43 | 0.08 | 18.20% |
| Q2 2021 Q2Q % growth | 0.62 226.32% | 0.42 | 0.20 | 47.85% |
| Q1 2021 Q2Q % growth | 0.37 1,025.00% | 0.32 | 0.05 | 14.15% |
| Q4 2020 Q2Q % growth | 0.50 308.33% | 0.54 | -0.04 | -8.15% |
| Q3 2020 Q2Q % growth | 0.25 247.06% | 0.20 | 0.05 | 25.88% |
| Q2 2020 Q2Q % growth | 0.19 290.00% | 0.25 | -0.06 | -24.33% |
| Q1 2020 Q2Q % growth | -0.04 -500.00% | -0.02 | -0.02 | -89.17% |
| Q4 2019 Q2Q % growth | -0.24 | -0.16 | -0.08 | -52.89% |
| Q3 2019 Q2Q % growth | -0.17 | -0.12 | -0.05 | -37.17% |
| Q2 2019 Q2Q % growth | -0.10 | -0.14 | 0.04 | 30.57% |
| Q1 2019 Q2Q % growth | 0.01 | 0.01 | 0.00 | -29.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 290.084M 34.28% | 256.08M | 34.004M | 13.28% |
| Q2 2024 Q2Q % growth | 231.353M 4.67% | 209.04M | 22.313M | 10.67% |
| Q1 2024 Q2Q % growth | 195.879M 20.81% | 203.77M | -7.891M | -3.87% |
| Q4 2023 Q2Q % growth | 230.039M 26.74% | 235.76M | -5.721M | -2.43% |
| Q3 2023 Q2Q % growth | 216.033M 3.37% | 220.43M | -4.397M | -1.99% |
| Q2 2023 Q2Q % growth | 221.038M 45.04% | 203.95M | 17.088M | 8.38% |
| Q1 2023 Q2Q % growth | 162.143M 38.23% | 179.02M | -16.877M | -9.43% |
| Q4 2022 Q2Q % growth | 181.5M 77.94% | 195.9M | -14.4M | -7.35% |
| Q3 2022 Q2Q % growth | 209M 80.48% | 194.93M | 14.07M | 7.22% |
| Q2 2022 Q2Q % growth | 152.4M 11.65% | 141.56M | 10.84M | 7.66% |
| Q1 2022 Q2Q % growth | 117.3M 31.80% | 130.82M | -13.52M | -10.33% |
| Q4 2021 Q2Q % growth | 102M -16.19% | 102.33M | -330K | -0.32% |
| Q3 2021 Q2Q % growth | 115.8M 77.34% | 107.74M | 8.06M | 7.48% |
| Q2 2021 Q2Q % growth | 136.5M 147.28% | 106.13M | 30.37M | 28.62% |
| Q1 2021 Q2Q % growth | 89M 250.39% | 86.576M | 2.424M | 2.80% |
| Q4 2020 Q2Q % growth | 121.7M 126.63% | 122.57M | -870K | -0.71% |
| Q3 2020 Q2Q % growth | 65.3M 41.34% | 62.12M | 3.18M | 5.12% |
| Q2 2020 Q2Q % growth | 55.2M 41.18% | 68.01M | -12.81M | -18.84% |
| Q1 2020 Q2Q % growth | 25.4M -55.36% | 43.821M | -18.421M | -42.04% |
| Q4 2019 Q2Q % growth | 53.7M | 58.067M | -4.367M | -7.52% |
| Q3 2019 Q2Q % growth | 46.2M | 56.031M | -9.831M | -17.55% |
| Q2 2019 Q2Q % growth | 39.1M | 43.619M | -4.519M | -10.36% |
| Q1 2019 Q2Q % growth | 56.9M | 69.159M | -12.259M | -17.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.42% | -4.66% | -0.43% | 4.21% |
| Revenue | -0.92% | 1.35% | 0.1% | 1.99% |